Vascular Disease Management
INSIGHT INTO DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE
MANAGEMENT
Thursday, May 15, 2008

SEARCH ARTICLES



Home | About
Current Issue
Archives
Subscribe
Board Members
Search Article Archives
Editor's Update
Events & Symposia
Industry News | Enews
Discussion Forum
Classifieds
Letter to the Editor
Comments/Suggestions
Editorial/Production
Author Information
Submit a Manuscript
Review a Manuscript
Order Article Reprints
Advertising
Advertising Specs
Online/Web Production

Featured Article

679
Vascular Disease Management - ISSN: 1553-8036 - Volume 4 - Issue 1 - January 2007
Michael Wilhelm, MD, Charles Andersen, MD, Scott Steele, MD
Subhash Banerjee, MD, Michael Cho, MD, *Shubam Gupta, MD, Emmanouil S. Brilakis, MD, PhD
Charles T. Burke, MD
Frank J. Criado, MD
Mitchell J. Silver, DO, Charles Botti, Jr, MD
Background: The purpose of this study was to determine the effectiveness of a side shield radiation protection method designed to decrease the scatter radiation exposure experienced by operators during cardiac catheterization procedures. Methods and Results: The study included 50 patients undergoing diagnostic cardiac catheterization. Scatter radiation exposure was measured directly with silicone diode dosimeters. Radiation doses were measured outside of protective lead draping worn by the operators at the abdominal and thyroid levels. The mean fluoroscopy times were similar between the control group, 1.86 (± 1.27) minutes and the protected group, 2.47 (± 1.90) minutes. The number of recorded cine angiographic runs was also the same at 10.36 (± 2.86) and 10.29 (± 2.35), respectively. The mean waist exposures utilizing the radiation protection method were reduced by 54%, p < .007 and the mean thyroid exposure were reduced by 8%, p = non significant. Conclusions: Th

EPics I Study: Evaluation of Possible Abdominal Aortic Aneurysms (in Patients who have undergone Previous CABG)
Carlo A. Dall’Olmo, MD, Allan L. Ippolito, MD, John M. McIlduff, MD, Wayne K. Kinning, MD, Gregory J. Fortin, MD, Scott A. Garner, MD, Robert G. Molnar, MD, Russell W. Becker, DO, David B. Wilson, MD, Fernando Jara, MD, Frederick Armenti, MD, Anup Sud, MD, Brenda S. Buckle, ANP, BC, Joanne E. Drago, RVT, Ann M. Innskeep, RVT
The study was undertaken to see if the prevalence of AAAs was higher in male and female subjects who had undergone coronary artery bypass grafting (CABG) than the 4% prevalence in men and the 1% prevalence in women reported in many large population based studies. Five-hundred seventeen (517) men and 235 females, 60 years of age and older who had undergone CABG, underwent screening of their abdominal aorta. Forty-seven (47) AAAs were found in men for a prevalence of 9.0% and 12 AAAs were found in women for a prevalence of 5.1%. Of the 47 AAAs found in men, two-thirds for 31 were discovered by the screening process and one-third (16) were known to the subjects. In women, 6 of the 12 AAAs were discovered by the screening process. Smoking, male gender and age were the most significant risk factors. We conclude that males and females who have undergone CABG have a higher prevalence of AAAs than the population at large. Furthermore, routine screening of the abdominal aorta should be perf

Commentary: Use of a Disposable Radiation Protective Table for Reducing Operator Radiation
Daniel Clair, MD

A Single Center Clinical Evaluation of Carotid Stenting for the Treatment of Obstructive Carotid Artery Disease: Experience in a Community Hospital
Michael B. DeYoung, DO, Timothy Logan, DO, Julie Burnham, DO, Samer Kazziha, MD
Objectives. Carotid angioplasty and stenting (CAS) is a less invasive alternative to conventional carotid endarterectomy (CEA). We sought to demonstrate that carotid angioplasty and stenting can be accomplished safely and successfully in a community hospital with results comparable to those attained in clinical trials at academic centers. Background. Trials performed in academic centers have concluded that CAS with an embolic protection device is not inferior to carotid endarterectomy in high-risk patients and has been shown to have fewer complications in the short term. Methods. We report prospective data on fifty consecutive cases utilizing a standardized carotid protocol at our institution performed by a single operator. CAS was completed in 48 high-risk patients. The majority (96%) of procedures included embolic protection devices. Neurological examination and duplex scans were performed at baseline and in follow-up (1 month, 6 months, and 1 year). Long-term re

Digital Periarterial Sympathectomy for Severe Ischemia of Raynaud’s Syndrome
1Alkiviadis Kalliakmanis, MD, 2Dimitrios Petratos, MD, 3John Ignantiadis, MD, 3Nikolaos Gerostathopoulos, MD

VASCULAR TOPICS

Peripheral Angioplasty
Thoracic Stent Grafts
Renal Stenting
Vena Cava Filter
Hemodialysis Management
Computed Tomography
PFO Closure
SFA Stenting
Carotid Stenting
Vessel Closure
Angiography
Carotid Endarterectomy
Ultrasound

Critical Limb Ischemia
Superficial Femoral Artery
Embolization
Device Based Thrombectomy
Pharmacological Management
MRA
Mesenteric Artery Stenting
AAA Stent Grafts
Iliac Stenting
Thrombolysis Procedures Using Drug Therapy

SUPPLEMENTS

Superior Mesenteric Artery Revascularization and Retrograde Visualization
This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

HMP Increased Cutaneous Sensibility in Patients with Diabetic Neuropathy Utilizing a Pharmacological Approach — Clinical Case Evidence

This clinical case update was supported through an unrestricted educational grant from Pamlab, LLC.

A New Biological Approachto Below-Knee Revascularization
A Review of the GORE PROPATEN Vascular Graft:
The Combination That Lasts

This special supplement was made possible through a grant from W. L. Gore

Combining Bilayered Living Cell Therapy with Minimally Invasive Vein Surgery:
Current Treatment Strategies for Venous Ulcers

This activity is supported by an educational grant from Organogenesis.

Pharmacotherapy in Peripheral Vascular Disease

Platelet Inhibition in Critical Limb Ischemia and Peripheral Vascular Interventions
DAVID E. ALLIE, MD

An Overview of Pharmacotherapy during Percutaneous Peripheral Interventions of Thrombotic Lesions
NICOLAS W. SHAMMAS, MD, MS, FACC


The Important Properties of Contrast Media: Focus on Viscosity

This special supplement was made possible through a grant from Guerbet LLC

RECENTLY ADDED

Anticoagulation Techniques for Peripheral Vascular Interventions

Archived Webcast





© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd., Suite 100, Malvern, PA 19355
Phone: 800.237.7285 610.560.0500 Fax: 610.560.0502
Privacy Policy